Mostrar el registro sencillo del ítem
The solid progress of nanomedicine
dc.contributor.author | Martins, J. P. | |
dc.contributor.author | das Neves, J. | |
dc.contributor.author | De La Fuente Freire, María | |
dc.contributor.author | Celia, C. | |
dc.contributor.author | Florindo, H. | |
dc.contributor.author | Guenday-Tureli, N. | |
dc.contributor.author | Popat, A. | |
dc.contributor.author | Santos, J. L. | |
dc.contributor.author | Sousa, F. | |
dc.contributor.author | Schmid, R. | |
dc.contributor.author | Wolfram, J. | |
dc.contributor.author | Sarmento, B. | |
dc.contributor.author | Santos, H. A. | |
dc.date.accessioned | 2022-05-05T08:27:47Z | |
dc.date.available | 2022-05-05T08:27:47Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 2190-393X | |
dc.identifier.other | https://www.ncbi.nlm.nih.gov/pubmed/32141035 | es |
dc.identifier.uri | http://hdl.handle.net/20.500.11940/16671 | |
dc.description.abstract | This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion. Graphical abstract. | en |
dc.rights | Atribución 4.0 Internacional | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject.mesh | National Cancer Institute (U.S.) | * |
dc.subject.mesh | Humans | * |
dc.subject.mesh | Nanomedicine | * |
dc.subject.mesh | Focus Groups | * |
dc.subject.mesh | Neoplasms | * |
dc.title | The solid progress of nanomedicine | en |
dc.type | Journal Article | es |
dc.authorsophos | Martins, J. P.;das Neves, J.;de la Fuente, M.;Celia, C.;Florindo, H.;Guenday-Tureli, N.;Popat, A.;Santos, J. L.;Sousa, F.;Schmid, R.;Wolfram, J.;Sarmento, B.;Santos, H. A. | |
dc.identifier.doi | 10.1007/s13346-020-00743-2 | |
dc.identifier.pmid | 32141035 | |
dc.identifier.sophos | 39815 | |
dc.issue.number | 3 | es |
dc.journal.title | DRUG DELIVERY AND TRANSLATIONAL RESEARCH | es |
dc.organization | Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS) | es |
dc.page.initial | 726 | es |
dc.page.final | 729 | es |
dc.rights.accessRights | openAccess | |
dc.subject.decs | grupos focales | * |
dc.subject.decs | nanomedicina | * |
dc.subject.decs | humanos | * |
dc.subject.decs | neoplasias | * |
dc.subject.decs | National Cancer Institute (U.S.) | * |
dc.subject.keyword | IDIS | es |
dc.typefides | Artículo Original | es |
dc.typesophos | Artículo Original | es |
dc.volume.number | 10 | es |